Ye, D., Lu, X., Shen, Y., Zhu, Y., Jiang, S., Zhang, L., Xu, D., Chen, H., Tang, Y., Li, H., Han, X., Yao, K., Wang, Y., Yang, Y., Chen, W., Xu, X., Lu, Y., Wang, C. (2026). Perioperative SHR-A2102, a novel nectin-4–targeted antibody-drug conjugate, in combination with adebrelimab for patients (pts) with muscle-invasive bladder cancer: Results from a phase 2/3 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4506